Peer-influenced content. Sources you trust. No registration required. This is HCN.
British Medical Journal (The BMJ)
New data suggests that the Galleri blood test’s sensitivity for early-stage cancers may be lower than initially reported, potentially limiting its utility as a screening tool.
Hematology/Oncology August 12th 2024
Oncology News Central (ONC)
The FDA advisory committee’s decision highlights the complexities of perioperative treatment in NSCLC and the need for more precise efficacy data to guide clinical decision-making.
Oncology, Medical August 12th 2024
The New England Journal of Medicine
In a phase 3 trial involving 5,338 cisgender women in South Africa and Uganda, twice-yearly lenacapavir injections demonstrated complete prevention of HIV infection, significantly outperforming daily oral medication regimens.
Clinical Pharmacology August 8th 2024
Practical Neurology
A phase 3 clinical trial of buntanetap in early Parkinson’s disease patients demonstrated improvements in motor and cognitive functions, particularly in those with longer disease duration and postural instability.
Clinical Pharmacology July 30th 2024
The DESTINY-Breast06 trial demonstrates the potential for earlier use of trastuzumab deruxtecan in HR+, HER2-low, and HER2-ultralow advanced or metastatic breast cancer, with significant improvements in progression-free survival compared to conventional chemotherapy.
Oncology, Medical July 29th 2024
The addition of blinatumomab to consolidation chemotherapy in adults with MRD-negative B-cell precursor ALL demonstrated a significant improvement in overall survival. At 3 years, the overall survival rate was 85% in the blinatumomab group compared to 68% in the chemotherapy-only group.
Hematology/Oncology July 29th 2024